Compugen EBIT

The latest EBIT for CGEN is $35M as of September 2026. That compares with $-30M in the prior-year period — up 214.4% year over year. That is below the Healthcare sector average of $2T. Investors often review this figure alongside Compugen's historical trend and sector peers before judging valuation or financial health.

Over the past year, CGEN's EBIT moved from $-30M to $35M — a 214.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Compugen's operating scale or balance-sheet position.

Against Healthcare companies, CGEN currently prints $35M for EBIT, while the sector average sits near $2T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Compugen's growth, margins, and balance sheet.

A EBIT figure of $35M for CGEN is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $2T. Explore the charts below for those layers of context.

After noting CGEN's EBIT ($35M), review year-over-year change from $-30M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.